Complement in fungal infections and complement evasion strategies

Immunology of Fungal Infections

Volumn , Issue , 2007, Pages 177-199

  Speth, Cornelia ^a   Lass Flörl, Cornelia ^a   Würzner, Reinhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53549101090     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/1-4020-5492-0_8     Document Type: Chapter

References (124)

1. Alaei, S., Larcher, C., Ebenbichler, C., Prodinger, W. M., Janatova, J. and Dierich, M. P. (1993) Isolation and biochemical characterization of the iC3b receptor of Candida albicans. Infect. Immun. 61, 1395-1399.
2. Akamatsu, H., Komura, J., Asada, Y., Miyachi, Y. and Niwa, Y. (1991) Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch. Dermatol. Res. 283, 162-166.
3. Ames, R. S., Li, Y., Sarau, H. M., et al. (1996) Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J. Biol. Chem. 271, 20231-20234.
4. Ashbee, H. R. and Evans, E. G. (2002) Immunology of diseases associated with Malassezia species. Clin. Microbiol. Rev. 15, 21-57.
5. Bergbrant, I. M., Johansson, S., Robbins, D., Scheynius, A., Faergemann, J. and Soderstrom, T. (1991) An immunological study in patients with seborrhoeic dermatitis. Clin. Exp. Dermatol. 16, 331-338.
6. Bergbrant, I. M. (1995) Seborrhoeic dermatitis and Pityrosporum yeasts. Curr. Top. Med. Mycol. 6, 95-112.
7. Bernhardt, J., Herman, D., Sheridan, M. and Calderone, R. (2001) Adherence and invasion studies of Candida albicans strains, using in vitro models of esophageal candidiasis. J. Infect. Dis. 184, 1170-1175.
8. Blackstock, R. and Murphy, J. W. (1997) Secretion of the C3 component of complement by peritoneal cells cultured with encapsulated Cyrptococcus neoformans. Infect. Immun. 65, 4114-4121.
9. Borges-Walmsley, M. I., Chen, D., Shu, X. and Walmsley, A. R. (2002) The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol. 10, 80-87.
10. Bradsher, R. W., Chapman, S. W. and Pappas, P. G. (2003) Blastomycosis. Infect. Dis. Clin. N. Am. 17, 21-40.
11. Brandhorst, T. T., Wütherich, M., Finkel-Jimenez, B., Warner, T. and Klein, B. S. (2004) Exploiting type 3 complement receptor for TNF-a suppression, immune evasion and progressive pulmonary fungal infection. J. Immunol. 173, 7444-7453.
12. Bullock, W. E. and Wright, S. D. (1987) Role of the adherence-promoting receptors, CR3, LFA-1, and p150, 95, in binding of Histoplasma capsulatum by human macrophages. J. Exp. Med. 165, 195-210.
13. Calderone, R. A., Linehan, L., Wadsworth, E. and Sandberg, A. L. (1988) Identification of C3d receptors on Candida albicans. Infect. Immun. 56, 252-258.
14. Calich, V. L., Kipnis, T. L., Mariano, M., Neto, C. F. and Dias Da Silva, W. D. (1979) The activation of the complement system by Paracoccidioides brasiliensis in vitro: its opsonic effect and possible significance for an in vivo model of infection. Clin. Immunol. Immunopathol. 12, 21-30.
15. Chequer-Bou-Habib, D., Oliveira-Neto, M. P., Ferreira-Da-Cruz, M. F., Galvao-Castro, B. (1989) The possibile role of circulating immune complexes in the deficiency of cell-mediated immunity in paracoccidioidomycosis. Braz. J. Med. Biol. Res. 22, 205-212.
16. Cosio, F. G., Shen, X. P., Birmingham, D. J., Van Aman, M. and Hebert, L. A. (1990) Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates. J. Immunol. 145, 4198-4206.
17. Cross, C. E., Collins, H. L. and Bancroft, G. J. (1997) CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complementopsonized Cryptococcus neoformans. Immunology 91, 289-296.
18. Crott, L. S., Valim, Y. M., Silva, C. L. and Barbosa, J. E. (1993) The role of the complement system in the neutrophil functions stimulated in vitro by an alkali-insoluble cell wall fraction of Paracoccidioides brasiliensis. J. Med. Vet. Mycol. 31, 17-27.
19. Crott, L. P., Lucisano-Valim, Y. M., Silva, C. L. and Barbosa, J. E. (1997) Interactions of F1 fractions from different strains of paracoccidioides brasiliensis with human complement and with human neutrophils. Mycopathologia 140, 19-27.
20. Daniels, R. H., Houston, W. A., Petersen, M. M., Williams, J. D., Williams, B. D. and Morgan, B. P. (1990) Stimulation of human rheumatoid synovial cells by non-lethal complement membrane attack. Immunology 69, 237-242.
21. Davies, S. F., Clifford, D. P., Hoidal, J. R. and Repine, J. E. (1982) Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonulear leukocytes and monocytes. J. Infect. Dis. 145, 870-874.
22. De Messias I. J, Reis, A., Brenden, M., Queiroz-Telles, F. and Mauff, G. (1991) Association of major histocompatibility complex class III complement components C2, BF and C4 with Brazilian paracoccidioidomycosis. Complement Inflamm. 8, 288-293.
23. De Messias, I. T. and Mohren, D. (1994) Classical and alternative complement pathway activation in paracoccidioidomycosis. J. Investig. Allergol Clin. Immunol. 4, 91-95.
24. Delfino, D., Cianci, L., Migliardo, M., Mancuso, G., Cusumano, V., Corradini, C. and Teti, G. (1996) Tumor necrosis factor-inducing activities of Cryptococcus neoformans components. Infect. Immun. 64, 5199-5204.
25. Denning, D. W. (1998) Invasive aspergillosis. Clin. Infect. Dis. 26, 781-803.
26. Diamond, R. D., Oppenheim, F., Nakagawa, Y., Krzesicki, R. and Haudenschild, C. C. (1980) Properties of a product of Candida albicans hyphae and pseudohyphae that inhibits contact between the fungi and human neutrophils in vitro. J. Immunol. 125, 2797-2804.
27. Diamond, R. D. and Haudenschild, C. C. (1981) Monocyte-mediated serum-independent damage to hyphal and pseudohyphal forms of Candida albicans in vitro. J. Clin. Invest. 67, 173-182.
28. Dong, Z. M. and Murphy, J. W. (1997) Cryptococcal polysaccharides bind to CD18 on human neutrophils. Infect. Immun. 65, 557-563.
29. Dovezenski, N., Billetta, R. and Gigli, I. (1992) Expression and localization of proteins of the complement system in human skin. J. Clin. Invest. 90, 2000-12.
30. Edwards, J. E., Gaither, T. A., O'Shea, J. J., et al. (1986) Expression of specific binding sites on Candida with functional and antigenic characteristics of human complement receptors. J. Immunol. 137, 3577-3583.
31. Eigentler, A., Schulz, T. F., Larcher, C., et al. (1989). C3bi-binding protein on Candida albicans: temperature-dependent expression and relationship to human complement receptor type 3. Infect. Immun. 57, 616-622.
32. Eisenstein, B. I. (1990) New opportunistic infections - more opportunities. N. Engl. J. Med. 323, 1625-1627.
33. Ember, J. A., Jagels, M. A. et al. (1998) Characterization of complement anaphylatoxins and their biological responses. In: JE Volanakis, MM Frank (eds) The human complement system in health and disease, Dekker M, New York, pp 241-284.
34. Faergemann, J., Bergbrant, I. M., Dohse, M., Scott, A. and Westgate, G. (2001) Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br. J. Dermatol. 144, 549-556.
35. Fidel, P. L. Jr. (2002) Immunity to Candida. Oral. Dis. 8(Suppl 2), 69-75.
36. Figueroa, J. E. and Densen, P. (1991) Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4, 359-395.
37. Finkel-Jimenez, B., Wuthrich, M. and Klein, B. S. (2002) BAD1, an essential virulence factor of Blastomyces dermatitidis, suppresses host TNF-alpha production through TGF-beta-dependent and - independent mechanisms. J. Immunol. 168, 5746-55.
38. Fulurija, A., Ashman, R. B. and Papadimitriou, J. M. (1996) Early inflammatory responses to Candida albicans infection in inbred and complement-deficient mice. FEMS Immunol. Med. Microbiol. 14, 83-94.
39. Gafa, V. and Manches, O., Pastor, A., Drouet, E., Ambroise-Thomas, P., Grillot, R. and Aldebert, D. (2005) Human cytomegalovirus downregulates complement receptors (CR3, CR4) and decreases phagocytosis by macrophages. J. Med. Virol. 76, 361-366.
40. Gale, C., Finkel, D., Tao, N., et al. (1996) Cloning and expression of a gene encoding an integrin-like protein in Candida albicans. Proc. Natl. Acad. Sci. U. S. A. 93, 357-361.
41. Gelfand, J. A., Hurley, D. L., Fauci, A. S. and Frank, M. M. (1978) Role of complement in host defense against experimental disseminated candidiasis. J. Infect. Dis. 138, 9-16.
42. Gerard, N. P. and Gerard, C. (1991) The chemotactic receptor for human C5a anaphylatoxin. Nature 349, 614-617.
43. Good, C. B. and Coax, W. A. (1990) Cryptococcal infection in patients with AIDS. N. Engl. J. Med. 322, 243-247.
44. Gruber, A., Lukasser-Vogl, E., Borg Von Zepelin, M., Dierich, M. P. and Würzner, R. (1998) Human immunodeficiency virus type 1 gp160/gp 41 binding to Candida albicans selectively enhances candidal virulence in vitro. J. Infect. Dis. 177, 1057-1063.
45. Gupta, A. K., Batra, R., Bluhm, R., Boekhout, T. and Dawson, T. L. (2004) Skin diseases associated with Malassezia species. J. Am. Acad. Dermatol. 51, 785-98.
46. Han, Y. and Cutler, J. E. (1995) Antibody response that protects against disseminated candidiasis. Infect. Immun. 63, 2714-2719.
47. Hector, R. F., Yee, E. and Collins, M. S. (1990) Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis. Infect. Immun. 58, 1476-1478.
48. Heidenreich, F. and Dierich, M. P. (1985) Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b. Infect. Immun. 50, 598-600.
49. Henwick, S., Hetherington, S. V. and Patrick, C. C. (1993) Complement binding to Aspergillus conidia correlates with pathogenicity. J. Lab. Clin. Med. 122, 27-35.
50. Hunter, C. A. (2005) IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521-31.
51. Ignatov, A. and Keath, E. J. (2002) Molecular cell biology and molecular genetics of Histoplasma capsulatum. Int. J. Med. Microbiol. 292, 349-361.
52. Ip, W. K. and Lau, Y. L. (2004) Role of mannose-binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells. J. Infect. Dis. 190, 632-640.
53. Jarvis, M. R. (1995) Epidemiology of nosokomial fungal infections, with emphasis on Candida species. Clin. Inf. Dis. 20, 1526-1530.
54. Kacani, L., Bánki, Z., Zwirner, J., Schennach, H., Baytay, Z., Erdei, A., Stoiber, H. and Dierich, M. P. (2000) C5a and C5adesArg enhance the susceptibility of monocyte-derived macrophages to HIV infection. J. Immunol. 166, 3410-3415.
55. Kaminishi, H., Miyaguchi, H., Tamaki, T., et al. (1995) Degradation of humoral host defense by Candida albicans proteinase. Infect. Immun. 63, 984-988.
56. Kelly, R. M., Chen, J., Yauch, L. E. and Levitz, S. M. (2005) Opsonic requirements for dendritic cellmediated responses to Cryptococcus neoformans. Infect. Immun. 73, 592-598.
57. Kesavan, S., Walters, C. E., Holland, K. T. and Ingham, E. (1998) The effects of Malassezia on proinflammatory cytokine production by human peripheral blood mononuclear cells in vitro. Med. Mycol. 36, 97-106.
58. King, I. L. and Segal, B. M. (2005) Cutting Edge: IL-12 Induces CD4+CD25-T Cell Activation in the Presence of T Regulatory Cells. J. Immunol. 175, 641-645.
59. Khoo, S. H. and Denning, D. W. (1994) Invasive aspergillosis in patients with AIDS. Clin. Infect. Dis. 19(Suppl 1), S41-48.
60. Kozel, T. R., Pfrommer, G. S., Guerlain, A. S., Highison, B. A. and Highison, G. J. (1988) Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect. Immun. 56, 2794-800.
61. Kozel, T. R., Wilson, M. A., Farrell, T. P. and Levitz, S. M. (1989) Activation of C3 and binding to Aspergillus fumigatus conidia and hyphae. Infect. Immun. 57, 3412-3417.
62. Kozel, T. (1996) Activation of the complement system by pathogenic fungi. Clin. Microbiol. Rev. 9, 34-46.
63. Kozel, T. R., Weinhold, L. C. and Lupan, D. M. (1996a) Distinct characteristics of initiation of the classical and alternative complement pathways by Candida albicans. Infect. Immun. 64, 3360-3368.
64. Kozel, T. R., Tabuni, A., Young, B. J. and Levitz, S. M. (1996b) Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells. Infect. Immun. 64, 2336-2338.
65. Kozel, T. R. (1998) Complement activation by pathogenic fungi. Res. Immunol. 149, 309-320.
66. Laxalt, K. A. and Kozel, T. R. (1979) Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 26, 435-440.
67. Levitz, S. M. and Tabuni, A. (1991) Binding of Cryptococcus neoformans by human cultured macrophages: requirements for multiple complement receptors and actin. J. Clin. Invest. 687, 528-535.
68. Levitz, S. M. (1992) Overview of host defences in fungal infections. Clin. Infect. Dis. 14(Suppl 1), S37-42.
69. Levitz, S. M., Tabuni, A., Kornfeld, H., Reardon, C. C. and Golenbock, D. T. (1994) Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun. 62, 1975-1981.
70. Levitz, S. M., Tabuni, A., Kozel, T. R., MacGill, R. S., Ingalls, R. R. and Golenbock, D. T. (1997) Binding of Cryptococcus neoformans to heterologously expressed human complement receptors. Infect. Immun. 65, 931-935.
71. Liles, W. C. and Van Hoorhis, W. C. (1995) Nomenclature and biological significance of cytokines involved in inflammation and the last immune response. J. Infect. Dis. 172, 1573-1580.
72. Long, J. G. and Keyserling, H. L. (1985) Catheter-related infection in infants due to an unusual lipophilic yeast-Malassezia furfur. Pediatrics 76, 896-900.
73. Long, K. H., Gomez, F. J., Morris, R. E. and Newman, S. L. (2003) Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J. Immunol. 170, 487-494.
74. Luo, Y., Tucker, S. C. and Casadevall, A. (2005) Fc- and complement-receptor activation stimulates cell cycle progression of macrophage cells from G1 to S. J. Immunol. 174, 7226-33.
75. Mackinnon, J. M. (1970) On the importance of South American Blastomycosis. Mycopathologia 41, 187-193.
76. Marth, T. and Kelsall, B. L. (1997) Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185, 1987-1995.
77. Martino, R. and Subira, M. (2002) Invasive fungal infections in hematology: new trends. Ann. Hematol. 81, 233-243.
78. Matsushima, K. and Oppenheim, J. J. (1989) Interleukin-8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1, 2-13.
79. Meri, T., Hartmann, A., Lenk, D., Eck, R., Wurzner, R., Hellwage, J., Meri, S. and Zipfel, P. F. (2002) The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect. Immun. 70, 5185-5192.
80. Meri, T., Blom, A. M., Hartmann, A., Lenk, D., Meri, S. and Zipfel, P. F. (2004) The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein. Infect. Immun. 72, 6633-6641.
81. Mold, C., Gurulé C., Otero, D., Du Clos, T. W. (1996) Complement-dependent binding of C-reactive protein complexes to human erythrocyte CR1. Clin. Immunol. Immunopathol. 81, 153-160.
82. Monari, C., Casadevall, A., Pietrella, D., Bistoni, F. and Vecchiarelli, A. (1999) Neutrophils from patients with advanced human immunodeficiency virus infection have impaired complement receptor function and reserved Fc receptor function. J. Infect. Dis. 180, 1542-1549.
83. Monari, C., Kozel, T. R., Bistoni, F. and Vecchiarelli, A. (2002) Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans. Infect. Immun. 70, 3363-3370.
84. Moors, M. A., Stull, T. L., Blank, K. J., Buckley, H. R. and Mosser, D. M. (1992) A role for complement receptor-like molecules in iron acquisition by Candida albicans. J. Exp. Med. 175, 1643-1651.
85. Morelli, R. and Rosenberg, L. T. (1971) The role of complement in the phagocytosis of Candida albicans by mouse peripheral blood leukocytes. J. Immunol. 107, 476-480.
86. Morgan, B. P. and Gasque, P. (1996) Expression of complement in the brain: role in health and disease. Immunol. Today 17, 461-466.
87. Mullick, A., Elias, M., Picard, S., Bourget, L., Jovcevski, O., Gauthier, S., Tuite, A., Harakidas, P., Bihun, C., Massie, B. and Gros, P. (2004) Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infect. Immun. 72, 5868-5876.
88. Munk, M. E., Kajdacsy-Balla, A., Del Negro, G., Cuce, L. C., Da Silva, W. D. (1992) Activation of human complement system in paracoccidioidomycosis. J. Med. Vet. Mycol. 30, 317-321.
89. Nardin, A., Lindorfer, M. A. and Taylor, R. P. (1999) How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells? Mol. Immunol. 36, 827-835.
90. Newman, S. L., Chaturvedi, S. and Klein, B. S. (1995) The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J. Immunol. 154, 753-761.
91. Odds, F. C. (1988) Candida and Candidosis. 2nd Edn. London: Baillière Tindall.
92. Pierard-Franchimont, C., Arrese, J. E. and Pierard, G. E. (1995) Immunohistochemical aspects of the link between Malassezia ovalis and seborrheic dermatitis. J. Eur. Acad. Dermatol. Venereol. 4, 14-19.
93. Prodinger, W. M., Würzner, R., Stoiber, H. and Dierich, M. P. (2003) Complement. In: Paul, W. E. (ed) Fundamental Immunology, Lippincott-Raven Publishers, Philadelphia, pp 1077-1103.
94. Rambach, G., Hagleitner, M., Mohsenipour, R., Lass-Flörl C., Maier, H., Würzner R., Dierich, M. P. and Speth, C. (2005) Antifungal activity of the local complement system in cerebral aspergillosis. Microb. Infect. 7, 1285-1295.
95. Ray, T. L. and Wuepper, K. D. (1976) Activation of the alternative (properdin) pathway of complement by Candida albicans and related species. J. Invest. Dermatol. 67, 700-703.
96. Redline, R. W., Redline, S. S., Boxerbaum, B. and Dahms, B. B. (1985) Systemic Malassezia furfur infections in patients receiving intralipid therapy. Hum. Pathol. 16, 815-22.
97. Schonermark, M., Deppisch, R., Riedasch, G., Rother, K. and Mansch, G. M. (1991) Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int. Arch. Allergy Appl. Immunol. 96, 331-337.
98. Speth, C., Würzner R., Stoiber, H. and Dierich, M. P. (1999) The complement system: pathophysiology and clinical relevance. Wien. Klin. Wochenschr. 111, 378-391.
99. Speth, C., Dierich, M. P. and Gasque, P. (2002) Neuroinvasion by pathogens: a key role of the complement system. Mol. Immunol. 38, 669-679.
100. Sturtevant, J. E. and Latgé, J. P. (1992a) Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect. Immun. 60, 1913-1918.
101. Sturtevant, J. and Latgé, J. P. (1992b) Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells. J. Infect. Dis. 166, 580-586.
102. Suzuki, T., Ohno, N. and Ohshima, Y. (1998a) Activation of complement system, alternative and classical pathways, by Malassezia furfur. Pharm. Pharmacol. Lett. 3, 133-136.
103. Suzuki, T., Ohno, N., Ohshima, Y. and Yadomae, T. (1998b) Soluble mannan and beta-glucan inhibit the uptake of Malassezia furfur by human monocytic cell line, THP-1. FEMS Immunol. Med. Microbiol. 21, 223-230.
104. Taborda, C. P. and Casadevall, A. (2002) CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16, 791-802.
105. Teixeira, J. E., Martinez, R., Camara, L. M. and Barbosa, J. E. (2001) Expression of complement receptor type 1 (CR1) on erythrocytes of paracoccidiodomycosis patients. Mycopathologia 152, 125-133.
106. Thong, Y. H. and Ferrante, A. (1978) Alternative pathway of complement activation by Candida albicans. Aust. N. Z. J. Med. 8, 620-622.
107. Tomee, J. C. and Kauffman, H. F. (2000) Putative virulence factors of Aspergillus fumigatus. Clin. Exp. Allergy 30, 476-484.
108. Triebel, T., Grillhösl. B., Kacani, L., Lell, C. P., Fuchs, A., Speth, C., Lass-Flörl., C., Steinmann, J., Dierich, M. P., Würzner, R. (2003) Importance of the terminal complement components for immune defence against Candida. Int. J. Med. Microbiol. 292, 527-536.
109. Tsai, H. F., Washburn, R. G., Chang, Y. C., Kwon-Chung, K. J. (1997) Aspergillus fumigatus arp1 modulates conidial pigmentation and complement deposition. Mol. Microbiol. 26, 175-184.
110. Tsai, H. F., Chang, Y. C., Washburn, R. G., Wheeler, M. H., Kwon-Chung, K. J. (1998) The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of cinidial morphology and virulence. J. Bacteriol. 180, 3031-3038.
111. Vecchierelli, A., Retini, C., Casadevall, A., Monari, C., Pietrella, D. and Kozel, T. R. (1998) Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans. Infect. Immun. 66, 4324-4330.
112. Waldorf, A. R. and Diamond, R. D. (1985) Neutrophil chemotactic responses induced by fresh and swollen Rhizopus oryzae spores and Aspergillus fumigatus conidia. Infect. Immun. 48, 458-463.
113. Washburn, R. G., Hammer, C. H. and Bennett, J. E. (1986) Inhibition of complement by culture supernatants of Aspergillus fumigatus. J. Infect. Dis. 154, 944-951.
114. Washburn, R. G., De Hart, D. J., Agwu, D. E., Bryant-Varela, B. J. and Julian, N. C. (1990) Aspergillus fumigatus complement inhibitor: production, characterization and purification by hydrophobic interaction and thin-layer chromatography. Infect. Immun. 58, 3508-3515.
115. Wilson, B. D. and Sohnle, P. G. (1988) Neutrophil accumulation and cutaneous responses in experimental cutaneous candidiasis of genetically complement-deficient mice. Clin. Immunol. Immunopathol. 46, 284-293.
116. Wright, M., Clausen, H. and Abrahamsen, T. (2004) Liver cells respond to Aspergillus fumigatus with an increase in C3 secretion and C3 gene expression as well as an expression in TLR2 and TLR4. Immunol. Lett. 95, 25-30.
117. Würzner, R., Langgartner, M., Spötl, L., et al. (1996) Temperature-dependent surface expression of the ß2-integrin analogue of Candida albicans and its role in adhesion to the human endothelium. Exp. Clin. Immunogenet. 13, 162-173.
118. Würzner, R., Gruber, A., Stoiber, H., et al. (1997) Human immunodeficiency virus type 1 gp41 binds to Candida albicans via complement C3-like regions. J. Infect. Dis. 176, 492-498.
119. Würzner, R., (1999) Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry. Mol. Immunol. 36, 249-260.
120. Würzner, R., (2003) Complement and infectious diseases. Contrib. Microbiol. 10, 1-17.
121. Young, B. J. and Kozel, T. R. (1993) Effects of strain variation, serotype and structural modification on the kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect. Immun. 61, 2966-2972.
122. Zhang, M. X. and Klein, B. (1997) Activation, binding and processing of complement component 3 (C3) by Blastomyces dermatitidis. Infect. Immun. 65, 1849-1855.
123. Zhang, M. X., Brandhorst, T. T., Kozel, T. R. and Klein, B. S. (2001) Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast. Infect. Immun. 69, 7559-7564.
124. Zhou, P., Sieve, M. C., Bennett, J., Kwon-Chung, K. J., Tewari, R. P., Gazzinelli, R. T., Sher, A. and Seder, R. A. (1995) IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J. Immunol. 155, 785-795.